Companion Diagnostic Tests in Oncology Market Report

China Companion Diagnostic Tests in Oncology Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • POSTDATE：Aug 22, 2022
  • PAGES：185
  • REPORT CODE：GMM1086266
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the China Companion Diagnostic Tests in Oncology market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Companion Diagnostic Tests in Oncology market. Detailed analysis of key players, along with key growth strategies adopted by Companion Diagnostic Tests in Oncology industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Abbott

    • Thermo Fisher

    • Genomic Health

    • QIAGEN

    • Agendia

    • Agilent

    • Roche

    • Illumina

    • BioMerieux

    • Siemens Healthcare

    By Type:

    • Protein Detection

    • DNA Detection

    By End-User:

    • Pharmaceutical & Biotechnology Companies

    • Medical Device Companies

    • Research Institutes

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Companion Diagnostic Tests in Oncology Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Companion Diagnostic Tests in Oncology Market Size and Growth Rate of Protein Detection from 2016 to 2027

    • 1.3.2 China Companion Diagnostic Tests in Oncology Market Size and Growth Rate of DNA Detection from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Companion Diagnostic Tests in Oncology Market Size and Growth Rate of Pharmaceutical & Biotechnology Companies from 2016 to 2027

    • 1.4.2 China Companion Diagnostic Tests in Oncology Market Size and Growth Rate of Medical Device Companies from 2016 to 2027

    • 1.4.3 China Companion Diagnostic Tests in Oncology Market Size and Growth Rate of Research Institutes from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Companion Diagnostic Tests in Oncology Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Companion Diagnostic Tests in Oncology Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Companion Diagnostic Tests in Oncology Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Companion Diagnostic Tests in Oncology Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Companion Diagnostic Tests in Oncology Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Companion Diagnostic Tests in Oncology Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Companion Diagnostic Tests in Oncology Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Companion Diagnostic Tests in Oncology Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Companion Diagnostic Tests in Oncology by Major Types

    • 3.4.1 Market Size and Growth Rate of Protein Detection

    • 3.4.2 Market Size and Growth Rate of DNA Detection

    4 Segmentation of Companion Diagnostic Tests in Oncology Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Companion Diagnostic Tests in Oncology by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Companion Diagnostic Tests in Oncology in Pharmaceutical & Biotechnology Companies

    • 4.4.2 Market Size and Growth Rate of Companion Diagnostic Tests in Oncology in Medical Device Companies

    • 4.4.3 Market Size and Growth Rate of Companion Diagnostic Tests in Oncology in Research Institutes

    5 Market Analysis by Regions

    • 5.1 China Companion Diagnostic Tests in Oncology Production Analysis by Regions

    • 5.2 China Companion Diagnostic Tests in Oncology Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Companion Diagnostic Tests in Oncology Landscape Analysis

    • 6.1 North China Companion Diagnostic Tests in Oncology Landscape Analysis by Major Types

    • 6.2 North China Companion Diagnostic Tests in Oncology Landscape Analysis by Major End-Users

    7 Central China Companion Diagnostic Tests in Oncology Landscape Analysis

    • 7.1 Central China Companion Diagnostic Tests in Oncology Landscape Analysis by Major Types

    • 7.2 Central China Companion Diagnostic Tests in Oncology Landscape Analysis by Major End-Users

    8 South China Companion Diagnostic Tests in Oncology Landscape Analysis

    • 8.1 South China Companion Diagnostic Tests in Oncology Landscape Analysis by Major Types

    • 8.2 South China Companion Diagnostic Tests in Oncology Landscape Analysis by Major End-Users

    9 East China Companion Diagnostic Tests in Oncology Landscape Analysis

    • 9.1 East China Companion Diagnostic Tests in Oncology Landscape Analysis by Major Types

    • 9.2 East China Companion Diagnostic Tests in Oncology Landscape Analysis by Major End-Users

    10 Northeast China Companion Diagnostic Tests in Oncology Landscape Analysis

    • 10.1 Northeast China Companion Diagnostic Tests in Oncology Landscape Analysis by Major Types

    • 10.2 Northeast China Companion Diagnostic Tests in Oncology Landscape Analysis by Major End-Users

    11 Southwest China Companion Diagnostic Tests in Oncology Landscape Analysis

    • 11.1 Southwest China Companion Diagnostic Tests in Oncology Landscape Analysis by Major Types

    • 11.2 Southwest China Companion Diagnostic Tests in Oncology Landscape Analysis by Major End-Users

    12 Northwest China Companion Diagnostic Tests in Oncology Landscape Analysis

    • 12.1 Northwest China Companion Diagnostic Tests in Oncology Landscape Analysis by Major Types

    • 12.2 Northwest China Companion Diagnostic Tests in Oncology Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Abbott

      • 13.1.1 Abbott Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Thermo Fisher

      • 13.2.1 Thermo Fisher Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Genomic Health

      • 13.3.1 Genomic Health Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 QIAGEN

      • 13.4.1 QIAGEN Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Agendia

      • 13.5.1 Agendia Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Agilent

      • 13.6.1 Agilent Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Roche

      • 13.7.1 Roche Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 Illumina

      • 13.8.1 Illumina Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 BioMerieux

      • 13.9.1 BioMerieux Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    • 13.10 Siemens Healthcare

      • 13.10.1 Siemens Healthcare Company Profile and Recent Development

      • 13.10.2 Market Performance

      • 13.10.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Companion Diagnostic Tests in Oncology Market Size and Growth Rate of Protein Detection from 2016 to 2027

    • Figure China Companion Diagnostic Tests in Oncology Market Size and Growth Rate of DNA Detection from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Companion Diagnostic Tests in Oncology Market Size and Growth Rate of Pharmaceutical & Biotechnology Companies from 2016 to 2027

    • Figure China Companion Diagnostic Tests in Oncology Market Size and Growth Rate of Medical Device Companies from 2016 to 2027

    • Figure China Companion Diagnostic Tests in Oncology Market Size and Growth Rate of Research Institutes from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Companion Diagnostic Tests in Oncology Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Companion Diagnostic Tests in Oncology Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Companion Diagnostic Tests in Oncology Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Companion Diagnostic Tests in Oncology Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Companion Diagnostic Tests in Oncology Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Companion Diagnostic Tests in Oncology Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Companion Diagnostic Tests in Oncology Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Companion Diagnostic Tests in Oncology Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Companion Diagnostic Tests in Oncology

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Companion Diagnostic Tests in Oncology by Different Types from 2016 to 2027

    • Table Consumption Share of Companion Diagnostic Tests in Oncology by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Protein Detection

    • Figure Market Size and Growth Rate of DNA Detection

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Companion Diagnostic Tests in Oncology by Different End-Users from 2016 to 2027

    • Table Consumption Share of Companion Diagnostic Tests in Oncology by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Pharmaceutical & Biotechnology Companies

    • Figure Market Size and Growth Rate of Medical Device Companies

    • Figure Market Size and Growth Rate of Research Institutes

    • Table China Companion Diagnostic Tests in Oncology Production by Regions

    • Table China Companion Diagnostic Tests in Oncology Production Share by Regions

    • Figure China Companion Diagnostic Tests in Oncology Production Share by Regions in 2016

    • Figure China Companion Diagnostic Tests in Oncology Production Share by Regions in 2021

    • Figure China Companion Diagnostic Tests in Oncology Production Share by Regions in 2027

    • Table China Companion Diagnostic Tests in Oncology Consumption by Regions

    • Table China Companion Diagnostic Tests in Oncology Consumption Share by Regions

    • Figure China Companion Diagnostic Tests in Oncology Consumption Share by Regions in 2016

    • Figure China Companion Diagnostic Tests in Oncology Consumption Share by Regions in 2021

    • Figure China Companion Diagnostic Tests in Oncology Consumption Share by Regions in 2027

    • Table North China Companion Diagnostic Tests in Oncology Consumption by Types from 2016 to 2027

    • Table North China Companion Diagnostic Tests in Oncology Consumption Share by Types from 2016 to 2027

    • Figure North China Companion Diagnostic Tests in Oncology Consumption Share by Types in 2016

    • Figure North China Companion Diagnostic Tests in Oncology Consumption Share by Types in 2021

    • Figure North China Companion Diagnostic Tests in Oncology Consumption Share by Types in 2027

    • Table North China Companion Diagnostic Tests in Oncology Consumption by End-Users from 2016 to 2027

    • Table North China Companion Diagnostic Tests in Oncology Consumption Share by End-Users from 2016 to 2027

    • Figure North China Companion Diagnostic Tests in Oncology Consumption Share by End-Users in 2016

    • Figure North China Companion Diagnostic Tests in Oncology Consumption Share by End-Users in 2021

    • Figure North China Companion Diagnostic Tests in Oncology Consumption Share by End-Users in 2027

    • Table Central China Companion Diagnostic Tests in Oncology Consumption by Types from 2016 to 2027

    • Table Central China Companion Diagnostic Tests in Oncology Consumption Share by Types from 2016 to 2027

    • Figure Central China Companion Diagnostic Tests in Oncology Consumption Share by Types in 2016

    • Figure Central China Companion Diagnostic Tests in Oncology Consumption Share by Types in 2021

    • Figure Central China Companion Diagnostic Tests in Oncology Consumption Share by Types in 2027

    • Table Central China Companion Diagnostic Tests in Oncology Consumption by End-Users from 2016 to 2027

    • Table Central China Companion Diagnostic Tests in Oncology Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Companion Diagnostic Tests in Oncology Consumption Share by End-Users in 2016

    • Figure Central China Companion Diagnostic Tests in Oncology Consumption Share by End-Users in 2021

    • Figure Central China Companion Diagnostic Tests in Oncology Consumption Share by End-Users in 2027

    • Table South China Companion Diagnostic Tests in Oncology Consumption by Types from 2016 to 2027

    • Table South China Companion Diagnostic Tests in Oncology Consumption Share by Types from 2016 to 2027

    • Figure South China Companion Diagnostic Tests in Oncology Consumption Share by Types in 2016

    • Figure South China Companion Diagnostic Tests in Oncology Consumption Share by Types in 2021

    • Figure South China Companion Diagnostic Tests in Oncology Consumption Share by Types in 2027

    • Table South China Companion Diagnostic Tests in Oncology Consumption by End-Users from 2016 to 2027

    • Table South China Companion Diagnostic Tests in Oncology Consumption Share by End-Users from 2016 to 2027

    • Figure South China Companion Diagnostic Tests in Oncology Consumption Share by End-Users in 2016

    • Figure South China Companion Diagnostic Tests in Oncology Consumption Share by End-Users in 2021

    • Figure South China Companion Diagnostic Tests in Oncology Consumption Share by End-Users in 2027

    • Table East China Companion Diagnostic Tests in Oncology Consumption by Types from 2016 to 2027

    • Table East China Companion Diagnostic Tests in Oncology Consumption Share by Types from 2016 to 2027

    • Figure East China Companion Diagnostic Tests in Oncology Consumption Share by Types in 2016

    • Figure East China Companion Diagnostic Tests in Oncology Consumption Share by Types in 2021

    • Figure East China Companion Diagnostic Tests in Oncology Consumption Share by Types in 2027

    • Table East China Companion Diagnostic Tests in Oncology Consumption by End-Users from 2016 to 2027

    • Table East China Companion Diagnostic Tests in Oncology Consumption Share by End-Users from 2016 to 2027

    • Figure East China Companion Diagnostic Tests in Oncology Consumption Share by End-Users in 2016

    • Figure East China Companion Diagnostic Tests in Oncology Consumption Share by End-Users in 2021

    • Figure East China Companion Diagnostic Tests in Oncology Consumption Share by End-Users in 2027

    • Table Northeast China Companion Diagnostic Tests in Oncology Consumption by Types from 2016 to 2027

    • Table Northeast China Companion Diagnostic Tests in Oncology Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Companion Diagnostic Tests in Oncology Consumption Share by Types in 2016

    • Figure Northeast China Companion Diagnostic Tests in Oncology Consumption Share by Types in 2021

    • Figure Northeast China Companion Diagnostic Tests in Oncology Consumption Share by Types in 2027

    • Table Northeast China Companion Diagnostic Tests in Oncology Consumption by End-Users from 2016 to 2027

    • Table Northeast China Companion Diagnostic Tests in Oncology Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Companion Diagnostic Tests in Oncology Consumption Share by End-Users in 2016

    • Figure Northeast China Companion Diagnostic Tests in Oncology Consumption Share by End-Users in 2021

    • Figure Northeast China Companion Diagnostic Tests in Oncology Consumption Share by End-Users in 2027

    • Table Southwest China Companion Diagnostic Tests in Oncology Consumption by Types from 2016 to 2027

    • Table Southwest China Companion Diagnostic Tests in Oncology Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Companion Diagnostic Tests in Oncology Consumption Share by Types in 2016

    • Figure Southwest China Companion Diagnostic Tests in Oncology Consumption Share by Types in 2021

    • Figure Southwest China Companion Diagnostic Tests in Oncology Consumption Share by Types in 2027

    • Table Southwest China Companion Diagnostic Tests in Oncology Consumption by End-Users from 2016 to 2027

    • Table Southwest China Companion Diagnostic Tests in Oncology Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Companion Diagnostic Tests in Oncology Consumption Share by End-Users in 2016

    • Figure Southwest China Companion Diagnostic Tests in Oncology Consumption Share by End-Users in 2021

    • Figure Southwest China Companion Diagnostic Tests in Oncology Consumption Share by End-Users in 2027

    • Table Northwest China Companion Diagnostic Tests in Oncology Consumption by Types from 2016 to 2027

    • Table Northwest China Companion Diagnostic Tests in Oncology Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Companion Diagnostic Tests in Oncology Consumption Share by Types in 2016

    • Figure Northwest China Companion Diagnostic Tests in Oncology Consumption Share by Types in 2021

    • Figure Northwest China Companion Diagnostic Tests in Oncology Consumption Share by Types in 2027

    • Table Northwest China Companion Diagnostic Tests in Oncology Consumption by End-Users from 2016 to 2027

    • Table Northwest China Companion Diagnostic Tests in Oncology Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Companion Diagnostic Tests in Oncology Consumption Share by End-Users in 2016

    • Figure Northwest China Companion Diagnostic Tests in Oncology Consumption Share by End-Users in 2021

    • Figure Northwest China Companion Diagnostic Tests in Oncology Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Abbott

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott

    • Figure Sales and Growth Rate Analysis of Abbott

    • Figure Revenue and Market Share Analysis of Abbott

    • Table Product and Service Introduction of Abbott

    • Table Company Profile and Development Status of Thermo Fisher

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Thermo Fisher

    • Figure Sales and Growth Rate Analysis of Thermo Fisher

    • Figure Revenue and Market Share Analysis of Thermo Fisher

    • Table Product and Service Introduction of Thermo Fisher

    • Table Company Profile and Development Status of Genomic Health

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genomic Health

    • Figure Sales and Growth Rate Analysis of Genomic Health

    • Figure Revenue and Market Share Analysis of Genomic Health

    • Table Product and Service Introduction of Genomic Health

    • Table Company Profile and Development Status of QIAGEN

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of QIAGEN

    • Figure Sales and Growth Rate Analysis of QIAGEN

    • Figure Revenue and Market Share Analysis of QIAGEN

    • Table Product and Service Introduction of QIAGEN

    • Table Company Profile and Development Status of Agendia

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Agendia

    • Figure Sales and Growth Rate Analysis of Agendia

    • Figure Revenue and Market Share Analysis of Agendia

    • Table Product and Service Introduction of Agendia

    • Table Company Profile and Development Status of Agilent

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Agilent

    • Figure Sales and Growth Rate Analysis of Agilent

    • Figure Revenue and Market Share Analysis of Agilent

    • Table Product and Service Introduction of Agilent

    • Table Company Profile and Development Status of Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche

    • Figure Sales and Growth Rate Analysis of Roche

    • Figure Revenue and Market Share Analysis of Roche

    • Table Product and Service Introduction of Roche

    • Table Company Profile and Development Status of Illumina

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Illumina

    • Figure Sales and Growth Rate Analysis of Illumina

    • Figure Revenue and Market Share Analysis of Illumina

    • Table Product and Service Introduction of Illumina

    • Table Company Profile and Development Status of BioMerieux

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioMerieux

    • Figure Sales and Growth Rate Analysis of BioMerieux

    • Figure Revenue and Market Share Analysis of BioMerieux

    • Table Product and Service Introduction of BioMerieux

    • Table Company Profile and Development Status of Siemens Healthcare

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Siemens Healthcare

    • Figure Sales and Growth Rate Analysis of Siemens Healthcare

    • Figure Revenue and Market Share Analysis of Siemens Healthcare

    • Table Product and Service Introduction of Siemens Healthcare


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US